Anondita Medicare IPO Day 3 Subscription Status: Subscribed 300.89 Times with Massive Investor Response

Anondita Medicare Limited's initial public offering (IPO) has demonstrated exceptional investor interest through its third and final day of subscription, with Anondita Medicare's stock price set at ₹137-145 per share reflecting outstanding market reception. The ₹69.50 crore IPO reached 300.89 times by 5:24:03 PM on day three, indicating exceptional investor interest in this condom manufacturing company incorporated in 2024.

Anondita Medicare IPO non-institutional investors segment leads with exceptional 531.82 times subscription, whilst individual investors demonstrate exceptional participation at 286.20 times and qualified institutional buyers (ex-anchor) show spectacular interest at 153.03 times, whilst anchor investors show complete participation at 1.00 times, reflecting exceptional investor confidence in this company.

Anondita Medicare IPO subscription reached exceptional 300.89 times on day three, led by Non-Institutional Investors (531.82x), Individual Investors (286.20x), and Qualified Institutional Buyers Ex-Anchor (153.03x). Total applications reached 2,88,034.

Subscription Status of Anondita Medicare IPO:

Here are the subscription details for Anondita Medicare IPO as of Day 3 (August 26, 2025, 5:24:03 PM):

Anondita Medicare IPO Reservation

Key Highlights - Day 3:

• Overall subscription reached exceptional 300.89 times, showing extraordinary improvement from day two's 41.11 times.
• Non-institutional investors category displaying exceptional interest at 531.82 times, building dramatically from day two's 56.77 times
• bNII category demonstrating outstanding performance at 641.02 times, building substantially from day two's 64.22 times
• Individual investors showing exceptional confidence at 286.20 times, building substantially from day two's 56.63 times
• sNII segment showing spectacular participation at 313.43 times, building substantially from day two's 41.87 times
• Qualified institutional buyers (ex-anchor) displaying exceptional growth at 153.03 times, building substantially from day two's 2.17 times
• Total applications reached 2,88,034, indicating exceptional investor participation for this SME IPO
• Cumulative bid amount reached ₹13,843.56 crores against the issue size of ₹69.50 crores

Anondita Medicare IPO - Day 2 Subscription at 41.11 Times

Key Highlights - Day 2:

• Overall subscription reaching strong 41.11 times, showing substantial improvement from day one's 3.44 times
• Individual investors showing strong performance at 56.63 times, building substantially from day one's 5.99 times
• Non-institutional investors displaying strong growth at 56.77 times, building substantially from day one's 1.93 times
• bNII segment demonstrating strong performance at 64.22 times, building substantially from day one's 1.43 times
• sNII category showing strong interest at 41.87 times, building substantially from day one's 2.94 times
• Qualified institutional buyers (ex-anchor) showing modest improvement at 2.17 times, building from day one's 0.11 times

Anondita Medicare IPO - Day 1 Subscription at 3.44 Times

Key Highlights - Day 1:

• Overall subscription reached moderate 3.44 times, showing solid initial investor interest
• Individual investors displaying strong confidence at 5.99 times, showing positive retail sentiment
• sNII segment showing moderate interest at 2.94 times, indicating reasonable smaller HNI participation
• Non-institutional investors showing modest performance at 1.93 times, with measured HNI appetite
• bNII category demonstrating modest performance at 1.43 times, showing cautious larger HNI interest
• Qualified institutional buyers showing minimal performance at 0.11 times, indicating limited institutional appetite

About Anondita Medicare Limited

Incorporated in 2024, Anondita Medicare Limited is an Indian condom manufacturing company engaged in producing flavored male condoms under the "COBRA" brand, with manufacturing facility in Noida, Uttar Pradesh, producing 562 million condoms annually and serving domestic and international markets across Southeast Asia, Africa and the Middle East.